Clinicopathologic features of invasive breast cancer (BC) diagnosed in carriers of germline PALB2, CHEK2 and ATM pathogenic variants.

被引：0
|
作者：
Scott, Danika
Kingham, Kerry
Hodan, Rachel
Ma, Cindy
Mills, Meredith
Ford, James M.
Kurian, Allison W.
Telli, Melinda L.
机构：
[1] Stanford Univ, Sch Med, Stanford, CA USA
[2] Stanford Univ, Stanford Canc Inst, Sch Med, Stanford, CA USA
[3] Stanford Hlth Care, Stanford, CA USA
[4] Stanford Univ, Sch Med, Stanford Canc Inst, Palo Alto, CA 94304 USA
[5] Stanford Univ, Stanford, CA 94305 USA
[6] Stanford Sch Med, Stanford, CA 94305 USA
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2020年 / 38卷 / 15期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
1549
引用
收藏
页数：2
相关论文
共 50 条
  • [41] Prevalence and risk factors of PALB2 germline pathogenic variants
    Kang, Min-Chae
    Jung, Ye-Ryeong
    Lee, Seeyoun
    Kang, Han-Sung
    Jung, So-Youn
    Lim, Myong Cheol
    Lee, Keun Seok
    Lee, Eun-Gyeong
    Kong, Sun-Young
    CANCER RESEARCH, 2024, 84 (06)
  • [42] Evolutionary Origin of Human PALB2 Germline Pathogenic Variants
    Chian, Jia Sheng
    Li, Jiaheng
    Wang, San Ming
    INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2023, 24 (14)
  • [43] The heterogeneous cancer phenotype of individuals with biallelic germline pathogenic variants in CHEK2
    Hinic, Snezana
    Cybulski, Cezary
    Van der Post, Rachel S.
    Vos, Janet R.
    Schuurs-Hoeijmakers, Janneke
    Brugnoletti, Fulvia
    Koene, Saskia
    Vreede, Lilian
    van Zelst-Stams, Wendy A. G.
    Kets, C. Marleen
    Haadsma, Maaike
    Spruijt, Liesbeth
    Wevers, Marijke R.
    Evans, D. Gareth
    Wimmer, Katharina
    Schnaiter, Simon
    Volk, Alexander E.
    Mollring, Anna
    de Putter, Robin
    Soikkonen, Leila
    Kahre, Tiina
    Tooming, Mikk
    de Jong, Mirjam M.
    Vaz, Fatima
    Mensenkamp, Arjen R.
    Genuardi, Maurizio
    Lubinski, Jan
    Ligtenberg, Marjolijn
    Hoogerbrugge, Nicoline
    de Voer, Richarda M.
    GENETICS IN MEDICINE, 2024, 26 (05)
  • [44] Phase 2 Trial Testing The PARP Inhibitor Niraparib In Patients With Advanced Pancreatic Cancer with Pathogenic Variants In BRCA 1, BRCA2, PALB2, ATM and CHEK2
    Huffman, Brandon M.
    Crowdis, Jett
    Yurgelun, Matthew B.
    Horick, Nora
    Li, Yvonne
    Huy Nguyen
    Parmar, Kalindi
    Kochupurakkal, Bose S.
    Enzinger, Andrea
    Giannakis, Marios
    McCleary, Nadine
    Ng, Kimmie
    Patel, Anuj K.
    Perez, Kimberly J.
    Rubinson, Douglas A.
    Schlechter, Benjamin L.
    Singh, Harshabad
    Lam, Helen
    Ramsey, Kaitlyn
    Andrews, Elizabeth
    Culnane, Leigh
    Bullock, Andrea
    Rattani, Ahmed
    Clark, Jeffrey
    Peters, Mary Linton
    Wolpin, Brian M.
    D'Andrea, Alan D.
    Shapiro, Geoffrey I.
    Aguirre, Andrew J.
    Cleary, James M.
    CANCER RESEARCH, 2024, 84 (17)
  • [45] Title: Histologic and Molecular Subtype of CHEK2 and PALB2 Associated Breast Cancers
    Agarwal, Indu
    Sullivan, Megan E.
    MODERN PATHOLOGY, 2018, 31 : 43 - 43
  • [46] Germline CHEK2 and ATM Variants in Myeloid and Other Hematopoietic Malignancies
    Ryan J. Stubbins
    Sophia Korotev
    Lucy A. Godley
    Current Hematologic Malignancy Reports, 2022, 17 : 94 - 104
  • [47] CHEK2 gene somatic loss in breast tumors from carriers of germline CHEK2 mutations
    Iyevleva, A.
    Aleksakhina, S.
    Sokolenko, A.
    Baskina, S.
    Venina, A.
    Anisimova, E.
    Bizin, I. V.
    Ivantsov, A. O.
    Imyanitov, E. N.
    ANNALS OF ONCOLOGY, 2021, 32 : S1232 - S1232
  • [48] Germline CHEK2 and ATM Variants in Myeloid and Other Hematopoietic Malignancies
    Stubbins, Ryan J.
    Korotev, Sophia
    Godley, Lucy A.
    CURRENT HEMATOLOGIC MALIGNANCY REPORTS, 2022, 17 (04) : 94 - 104
  • [49] Clinical utility of testing for PALB2 and CHEK2 c.1100delC in breast and ovarian cancer
    Woodward, Emma R.
    van Veen, Elke M.
    Forde, Claire
    Harkness, Elaine F.
    Byers, Helen J.
    Ellingford, Jamie M.
    Burghel, George J.
    Schlech, Helene
    Bowers, Naomi L.
    Wallace, Andrew J.
    Howell, Sacha J.
    Howell, Anthony
    Lalloo, Fiona
    Newman, William G.
    Smith, Miriam J.
    Gareth Evans, D.
    GENETICS IN MEDICINE, 2021, 23 (10) : 1969 - 1976
  • [50] Clinical and Pathological Features of CHEK2 Mutation Carriers in Breast Cancer
    Lloyd, Christopher
    Rocha, Heather
    Ortiz, Nicole
    Mehr, Chelsea
    LABORATORY INVESTIGATION, 2023, 103 (03) : S174 - S175
12345